2 assets in Dysthymic Disorder

Therapeutic assets addressing Dysthymic Disorder, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Escitalopram Dysthymic Disorder	Nova Scotia Health Authority	P4	BBB (76)
Nicotine Dysthymic Disorder	Wake Forest University Health Sciences	N/A	D (30)